Apellis Pharmaceuticals, Inc. (APLS)

25.31 +0.75 (+3.05%) USD  |  NASDAQ  |  Dec 16, 16:00
25.71 +0.40 (+1.58%) Pre-Market: 09:25
More

Apellis Pharmaceuticals Price Target Upside (Daily)

Price Target Upside (Daily) Chart

View Price Target Upside (Daily) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Upside (Daily) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Upside (Daily) Range, Past 5 Years

View Price Target Upside (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Upside (Daily) Benchmarks

View Price Target Upside (Daily) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Ultragenyx Pharmaceutical, Inc. Upgrade
Fulcrum Therapeutics, Inc. Upgrade